Is Fennec Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: FENC) stock is to Strong Buy FENC stock.
Out of 2 analysts, 1 (50%) are recommending FENC as a Strong Buy, 1 (50%) are recommending FENC as a Buy, 0 (0%) are recommending FENC as a Hold, 0 (0%) are recommending FENC as a Sell, and 0 (0%) are recommending FENC as a Strong Sell.
What is FENC's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: FENC) forecast ROE is N/A, which is considered weak.
What is FENC's Price Target?
According to 2 Wall Street analysts that have issued a 1 year FENC price target, the average FENC price target is $16.50, with the highest FENC stock price forecast at $17.00 and the lowest FENC stock price forecast at $16.00.
On average, Wall Street analysts predict that Fennec Pharmaceuticals's share price could reach $16.50 by Aug 4, 2024. The average Fennec Pharmaceuticals stock price prediction forecasts a potential upside of 116.54% from the current FENC share price of $7.62.
What is FENC's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: FENC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.08%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.